Ulrike Hövelmann

Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control

Susanne Famulla, Ulrike Hövelmann, Annelie Fischer et al. · Diabetes Care · 2016 · 159 citations

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine

Tim Heise, Ulrike Hövelmann, Leszek Nosek et al. · Expert Opinion on Drug Metabolism & Toxicology · 2015 · 146 citations

Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

Tim Heise, Ulrike Hövelmann, Lise Brøndsted et al. · Diabetes Obesity and Metabolism · 2015 · 144 citations · Full text

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog

Ulrike Hövelmann, Britta Væver Bysted, Ulrik Mouritzen et al. · Diabetes Care · 2017 · 108 citations

Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes

Ronald J. Pettis, Laurence Hirsch, Christoph Kapitza et al. · Diabetes Technology & Therapeutics · 2011 · 72 citations